Search
for
Sort by
Research 91–120 of 1000+
- Hair loss after SARS-CoV2 Infection
- Evaluating cepharanthine analogues as natural drugs against SARS-CoV-2
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Virtual Screening of Potential Inhibitors for SARS-CoV-2 Main Protease
- Genetic Variants and Protective Immunity against SARS-CoV-2
- TMPRSS2: A Key Host Factor in SARS-CoV-2 Infection and Potential Therapeutic Target
- The clinical course and outcomes of SARS-CoV-2 virus infection in children: a 24-week follow-up study in Sulaimaniyah, Iraq
- Identifying long-term effects of SARS-CoV-2 and their association with social determinants of health in a cohort of over one million COVID-19 survivors
- The role of testosterone in SARS-CoV-2 infection
- Identifying Long-Term Effects of SARS-CoV-2 and Their Association with Social Determinants of Health in a Cohort of Over One Million COVID-19 Survivors
- Network-based identification genetic effect of SARS-CoV-2 infections to Idiopathic pulmonary fibrosis (IPF) patients
- Medical education and care in dermatology during the SARS‐CoV2 pandemia: challenges and chances
- Discovery of COVID-19 Inhibitors Targeting the SARS-CoV2 Nsp13 Helicase
- Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 <i>in vitro</i> infection using a phenotypic screening strategy and network-analysis to predict their potential to treat covid-19
- Genomic Surveillance Reveals the Rapid Expansion of the XBB Lineage among Circulating SARS-CoV-2 Omicron Lineages in Southeastern Wisconsin, USA
- Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period
- Natural Products as A Promising Therapy for SARS COV-2; An Overview
- Genetic and hormonal influence on SARS-CoV-2-infection susceptibility
- Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
- Research progress of post-acute sequelae after SARS-CoV-2 infection
- Impact of the new corona virus (SARS-CoV-2) pandemic on climateric women’s health: websurvey
- MANIFESTAÇÕES CUTÂNEAS CORROBORADAS À INFECÇÃO POR SARS-COV-2
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
- Enzalutamide, a prostate cancer therapeutic, downregulates TMPRSS2 in lung and reduces cellular entry of SARS-CoV-2
- Host-directed FDA-approved drugs with antiviral activity against SARS-CoV-2 identified by hierarchical <i>in silico/in vitro</i> screening methods
- Computational screening of repurposed drugs and natural products against SARS-Cov-2 main protease (Mpro) as potential COVID-19 therapies
- Antiviral effects of human placenta hydrolysate (Laennec®) against SARS-CoV-2 in vitro and in the ferret model
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods